Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml

Many efforts to reduce prostate specific antigen (PSA) overdiagnosis and overtreatment have been made. To this aim, Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) have been proposed as new more specific biomarkers. We evaluated the ability of phi and PCA3 to identify prostate cance...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ferro, Matteo, Bruzzese, Dario, Perdonà, Sisto, Marino, Ada, Mazzarella, Claudia, Perruolo, Giuseppe, D’Esposito, Vittoria, Cosimato, Vincenzo, Buonerba, Carlo, Di Lorenzo, Giuseppe, Musi, Gennaro, De Cobelli, Ottavio, Chun, Felix K., Terracciano, Daniela
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2013
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3701535/
https://ncbi.nlm.nih.gov/pubmed/23861782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0067687
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים